Gregers Wegener
Cited by
Cited by
Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder
A Mørk, A Pehrson, LT Brennum, SM Nielsen, H Zhong, AB Lassen, ...
Journal of Pharmacology and Experimental Therapeutics 340 (3), 666-675, 2012
Reference genes for normalization: a study of rat brain tissue
BE Bonefeld, B Elfving, G Wegener
Synapse 62 (4), 302-309, 2008
Stress–restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus
BH Harvey, F Oosthuizen, L Brand, G Wegener, DJ Stein
Psychopharmacology 175 (4), 494-502, 2004
The flinders sensitive line rat model of depression—25 years and still producing
DH Overstreet, G Wegener
Pharmacological reviews 65 (1), 143-155, 2013
Antidepressant-and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice
V Volke, G Wegener, M Bourin, E Vasar
Behavioural brain research 140 (1-2), 141-147, 2003
Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo
G Wegener, V Volke, R Rosenberg
British journal of pharmacology 130 (3), 575-580, 2000
Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity
G Wegener, V Volke, BH Harvey, R Rosenberg
Brain research 959 (1), 128-134, 2003
Animal models of depression and anxiety: What do they tell us about human condition?
ID Neumann, G Wegener, JR Homberg, H Cohen, DA Slattery, J Zohar, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (6), 1357-1375, 2011
Central functions of neuropeptide Y in mood and anxiety disorders
G Wu, A Feder, G Wegener, C Bailey, S Saxena, D Charney, AA Mathé
Expert opinion on therapeutic targets 15 (11), 1317-1331, 2011
Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus
F Chen, TM Madsen, G Wegener, JR Nyengaard
European Neuropsychopharmacology 19 (5), 329-338, 2009
Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats
IL Heiberg, G Wegener, R Rosenberg
Behavioural brain research 134 (1-2), 479-484, 2002
Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression
PA Melas, M Rogdaki, A Lennartsson, K Björk, H Qi, A Witasp, M Werme, ...
International Journal of Neuropsychopharmacology 15 (5), 669-679, 2012
Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression
B Elfving, PH Plougmann, HK Müller, AA Mathé, R Rosenberg, ...
International Journal of Neuropsychopharmacology 13 (5), 563-572, 2010
FTIR characterization of copper ethanolamine—wood interaction for wood preservation
J Zhang, DP Kamdem
Holzforschung 54 (2), 119-122, 2000
Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression
F Chen, TM Madsen, G Wegener, JR Nyengaard
Hippocampus 20 (12), 1376-1384, 2010
Nitric oxide synthase inhibitors as antidepressants
G Wegener, V Volke
Pharmaceuticals 3 (1), 273-299, 2010
Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase
A Petzer, BH Harvey, G Wegener, JP Petzer
Toxicology and applied pharmacology 258 (3), 403-409, 2012
Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex
G Treccani, L Musazzi, C Perego, M Milanese, N Nava, T Bonifacino, ...
Molecular Psychiatry 19 (4), 433-443, 2014
Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions
B Elfving, PH Plougmann, G Wegener
Journal of neuroscience methods 187 (1), 73-77, 2010
Probiotic treatment reduces depressive-like behaviour in rats independently of diet
A Abildgaard, B Elfving, M Hokland, G Wegener, S Lund
Psychoneuroendocrinology 79, 40-48, 2017
The system can't perform the operation now. Try again later.
Articles 1–20